PeptideDB

(3S,4S)-A2-32-01

(3S,4S)-A2-32-01

CAS No.:

(3S,4S)-A2-32-01 (compound 24(S,S)), the less active (S,S)-enantiomer of A2-32-01. A2-32-01 is a potent caseinolytic pro
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

(3S,4S)-A2-32-01 (compound 24(S,S)), the less active (S,S)-enantiomer of A2-32-01. A2-32-01 is a potent caseinolytic protease (ClpP) inhibitor.

Physicochemical Properties


Molecular Formula C19H27NO2
Molecular Weight 301.42
Related CAS # (3R,4R)-A2-32-01;1359752-95-6
Appearance Colorless to light yellow ointment
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. The mechanism of caseinolytic protease (ClpP) inhibition. Angew Chem Int Ed Engl. 2013 Mar 4;52(10):3009-14.


Solubility Data


Solubility (In Vitro) DMSO :~100 mg/mL (~331.76 mM)
Solubility (In Vivo) Solubility in Formulation 1: 1.25 mg/mL (4.15 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 1.25 mg/mL (4.15 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 1.25 mg/mL (4.15 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.3176 mL 16.5881 mL 33.1763 mL
5 mM 0.6635 mL 3.3176 mL 6.6353 mL
10 mM 0.3318 mL 1.6588 mL 3.3176 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.